Protecting bioinformatics’ value

As the field matures, so too must intellectual property strategies to capitalize o­n bioinformatics’ wealth. Bioinformatics—the use of computers to characterize the molecular components of living things and other biological data—is still a youngster in the life sciences family. By combining the revolutionary tools of information technology with biotechnology, bioinformatics channels the flood of information pouring from genomics and proteomics laboratories and promises to accelerate the discovery of new diagnostics and therapeutics.

For full article Click Here

Author(s): 
Michael A. Gollin.
Journal: 
Modern Drug Discovery, Oct 2004.